Decreasing Cyclic GMP Exerts Similar Positive Functional Effects on Cardiac Myocytes Regardless of Initial Level

Publisher： Karger

E-ISSN： 1423-0313|61|1|51-56

ISSN： 0031-7012

Source： Pharmacology, Vol.61, Iss.1, 2000-07, pp. : 51-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SERCA Inhibition Limits the Functional Effects of Cyclic GMP in Both Control and Hypertrophic Cardiac Myocytes

By  

Pharmacology, Vol. 83, Iss. 4, 2009-03 ,pp. : 223-230

Karger

Access to resources Recommend Favorite

Cyclic GMP-Induced Reduction in Cardiac Myocyte Function Is Partially Mediated by Activation of the Sarcoplasmic Reticulum Ca2+-ATPase

By  

Pharmacology, Vol. 64, Iss. 2, 2002-01 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Ethanol Reduces Cardiac Myocyte Function through Activation of the Nitric Oxide-Cyclic GMP Pathway

By  

Pharmacology, Vol. 67, Iss. 2, 2003-01 ,pp. : 59-66

Karger

Access to resources Recommend Favorite

Functional Interaction of a β-Adrenergic Agonist and Cyclic GMP Phosphodiesterase Inhibitor in Control and Hypertrophic Cardiomyocytes

By  

Pharmacology, Vol. 76, Iss. 2, 2006-01 ,pp. : 53-60

Karger

Access to resources Recommend Favorite

Increased O2 Consumption and Positive Inotropy Caused by Cyclic GMP Reduction Are Not Altered after L-Type Calcium Channel Blockade

By  

Pharmacology, Vol. 56, Iss. 1, 1998-01 ,pp. : 37-45

Karger

Access to resources Recommend Favorite